Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.

Source:http://linkedlifedata.com/resource/pubmed/id/21343372

Clin. Cancer Res. 2011 Apr 15 17 8 2328-38

Download in:

View as

General Info

PMID
21343372